Latest Capital Raises News

Aquirian Limited reported a 12.6% revenue increase to $26.07 million for FY25 but posted a $3.41 million statutory loss amid ramp-up costs and impairments. The company is advancing its Energetics and Technology divisions, including the Wubin Emulsion Facility and Collar Keeper® System.

Qoria Limited reported a robust FY2025 with 25% growth in annual recurring revenue and a 684% jump in EBITDA, underscoring its expanding leadership in global K12 safety and wellbeing platforms.

Mineral Resources Limited reports a challenging FY25 marked by lithium price volatility and operational hurdles, but highlights strong progress at Onslow Iron and a strategic focus on governance and deleveraging.

IDP Education’s FY25 results reveal a 14% revenue decline amid a 29% drop in student placement volumes, but strong price growth and cost discipline underpin a multi-year transformation aimed at future profitability.

IDP Education reports a 14% revenue decline in FY25 due to policy restrictions impacting student volumes, while unveiling a multi-year transformation program aimed at cost reduction and digital innovation.

IDP Education Limited reported a 15% revenue decline and a 66% drop in net profit for FY25, driven by sustained policy restrictions across key international student markets. The company is responding with a multi-year transformation program focused on cost reduction and AI-driven innovation.

Sprintex Limited reported a 26% revenue increase for FY25 but also a 37% rise in net loss, as it accelerates global expansion through key distribution deals and manufacturing upgrades.

Midas Minerals has secured a crucial licence transfer for its Otavi Copper Project acquisition in Namibia, moving closer to drilling plans slated for late 2025. The company now awaits final regulatory approval and capital raising to complete the deal.

Centuria Industrial REIT (ASX – CIP) has announced a $300 million exchangeable notes offering due 2030, alongside a concurrent repurchase of existing notes, aiming to lower debt costs and extend maturity. The move underscores CIP’s strategic capital management amid a complex market environment.

Biotron Limited reported a significantly reduced net loss of $318,572 for FY2025, bolstered by a $1.27 million capital raise and a $1.81 million R&D tax rebate, as it advances clinical and preclinical antiviral programs.

Gryphon Capital Income Trust (ASX, GCI) reported a robust fiscal 2025 with a 41.65% jump in revenue and a substantial capital raise to expand its RMBS/ABS portfolio. The Trust’s net assets topped $1 billion, reflecting strong investor confidence and strategic growth.

Flight Centre Travel Group has launched a A$450 million convertible notes offering due 2032, aiming to repurchase up to A$325 million of existing notes and support its growth ambitions with extended debt maturity.